Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Transcriptomic meta-analysis of multiple sclerosis and its experimental models.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
The origins of multiple sclerosis: a synthesis
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Regulatory effects of fisetin on microglial activation.
[Anti-NMDA receptor encephalitis - case report].
Enhancement of Membrane B7-H3 Costimulatory Molecule but Reduction of Its Soluble Form in Multiple Sclerosis.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition.
Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial.
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
Low dose naltrexone for induction of remission in Crohn's disease.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Influence of treatments in multiple sclerosis disability: A cohort study.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Warner Chilcott sells Vectrin product line to Medicis
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.
Tenascins and inflammation in disorders of the nervous system.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS

Pages